Minerva endocrinologyPub Date : 2023-09-01Epub Date: 2022-10-26DOI: 10.23736/S2724-6507.22.03868-4
Hasan Ulubasoglu, Necati Hancerliogullari, Aytekin Tokmak, H Levent Keskin, Tuba Candar, Ozlem Moraloglu Tekin
{"title":"Low sirtuin-1 levels are associated with gestational diabetes mellitus.","authors":"Hasan Ulubasoglu, Necati Hancerliogullari, Aytekin Tokmak, H Levent Keskin, Tuba Candar, Ozlem Moraloglu Tekin","doi":"10.23736/S2724-6507.22.03868-4","DOIUrl":"10.23736/S2724-6507.22.03868-4","url":null,"abstract":"BACKGROUND\u0000This study aims to determine whether sirtuin 1 (SIRT1), which has a regulatory role in glucose and lipid metabolism with its deacetylase activity, has a decisive role in predicting gestational diabetes (GDM).\u0000\u0000\u0000METHODS\u0000This study was performed at the antenatal outpatient clinic of Ankara City Hospital between January 2021 and May 2021. A total of 525 women with low-risk pregnancy underwent the 75 g oral glucose tolerance test (OGTT) between 24th-28th weeks of pregnancy during the study period. Fasting serum SIRT 1 levels of patients diagnosed with GDM according to OGTT results were compared some of those without GDM.\u0000\u0000\u0000RESULTS\u0000Of the 525 pregnant women who underwent 75 g OGTT, 50 (9.6%) were diagnosed with GDM. The data of pregnant women with GDM were compared with age and body mass index matched 122 controls. While serum SIRT1 levels were 22.0 (19.9-24.3) ng/mL in the GDM group, it was 34.7 (28.8-54.6) ng/ml in the control group (p<0.001). ROC curve analysis showed that a threshold level for serum SIRT1 equal to or greater than 27.3 ng/ml may predict GDM with a sensitivity of 86% and specificity of 80%.\u0000\u0000\u0000CONCLUSIONS\u0000Second-trimester low serum SIRT1 levels are associated with GDM. It may be a diagnostic marker for GDM.","PeriodicalId":18690,"journal":{"name":"Minerva endocrinology","volume":"48 3","pages":"282-287"},"PeriodicalIF":4.1,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10660039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Relationships between microvascular complications of diabetes mellitus and levels of macro and trace elements","authors":"Zeliha TEMURER AFŞAR, Berçem AYÇIÇEK, Yasemin TÜTÜNCÜ, Ümit ÇAVDAR, Engin SENNAROĞLU","doi":"10.23736/s2724-6507.20.03139-9","DOIUrl":"https://doi.org/10.23736/s2724-6507.20.03139-9","url":null,"abstract":"BACKGROUND: The aim of this study was to determine relationships between microvascular complications of type 2 diabetes mellitus (T2DM) and trace element levels measured by ICP-MS.METHODS: One hundred eighteen patients with T2DM (age: 30-65 years) and 40 control subjects were included in the study. The T2DM patients were divided into three groups according to their types of microvascular complications. Patients in group 1 (N.=40) had no microvascular complications. Group 2 included 38 patients with only diabetic retinopathy. Group 3 included 40 patients with diabetic retinopathy and nephropathy. Trace elements, including chromium (Cr), copper (Cu), and zinc (Zn), were measured by inductively coupled plasma mass spectrophotometry (ICP-MS).RESULTS: Mg levels analyzed by ICP-MS were lower in patients with T2DM than in healthy subjects. Additionally, Mg level of 2.1 mg/dL or less was found to be predictive for risk of occurrence of T2DM with no microvascular complications. Cr levels were significantly lower in T2DM patients with diabetic retinopathy and diabetic nephropathy than in T2DM patients with no microvascular complications. Additionally, levels of Cr were much lower significantly in group 3 than in group 2. The predictive value of Cr levels (area under the curve [AUC]=0.734, P=0.007) for occurrence of diabetic retinopathy was 15.2 μg/L (sensitivity = 70%; specificity = 60.5%).CONCLUSIONS: This study showed an association between especially low Mg and Cr levels measured via ICP-MS and microvascular complications in patients with T2DM.","PeriodicalId":18690,"journal":{"name":"Minerva endocrinology","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135387801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Minerva endocrinologyPub Date : 2023-09-01Epub Date: 2021-01-12DOI: 10.23736/S2724-6507.20.03323-4
Halit Diri, Bercem Aycicek
{"title":"A retrospective comparison between intensive and nonintensive insulin regimens in type 2 diabetes mellitus.","authors":"Halit Diri, Bercem Aycicek","doi":"10.23736/S2724-6507.20.03323-4","DOIUrl":"10.23736/S2724-6507.20.03323-4","url":null,"abstract":"<p><strong>Background: </strong>This study compared the outcomes between intensive and nonintensive insulin regimens and assessed the predictive factors for failing to achieve the glycated hemoglobin (A1C) goals in type-2-diabetes-mellitus (T2DM) patients requiring insulin therapy.</p><p><strong>Methods: </strong>A single-center, retrospective assessment of the medical records of 125 T2DM patients undergoing intensive (46 patients) and nonintensive insulin therapy (79 patients) were conducted.</p><p><strong>Results: </strong>No significant differences were found when the intensive and nonintensive insulin therapy groups were compared in terms of the percentage decreases of glucose and A1C levels. The mean A1C levels of the nonintensive and intensive groups declined from 11.15% and 11.30% to 7.97% and 8.06%, respectively.</p><p><strong>Conclusions: </strong>Both intensive and nonintensive insulin therapies improved the baseline glycemic parameters but being overweight or obese and/or being reluctant to dietary recommendations led to treatment failures regardless of the insulin regimen.</p>","PeriodicalId":18690,"journal":{"name":"Minerva endocrinology","volume":"48 3","pages":"311-317"},"PeriodicalIF":4.1,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10290232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Relationships between microvascular complications of diabetes mellitus and levels of macro and trace elements.","authors":"Zeliha Temurer Afşar, Berçem Ayçiçek, Yasemin Tütüncü, Ümit Çavdar, Engin Sennaroğlu","doi":"10.23736/S0391-1977.20.03139-9","DOIUrl":"10.23736/S0391-1977.20.03139-9","url":null,"abstract":"<p><strong>Background: </strong>The aim of this study was to determine relationships between microvascular complications of type 2 diabetes mellitus (T2DM) and trace element levels measured by ICP-MS.</p><p><strong>Methods: </strong>One hundred eighteen patients with T2DM (age: 30-65 years) and 40 control subjects were included in the study. The T2DM patients were divided into three groups according to their types of microvascular complications. Patients in group 1 (N.=40) had no microvascular complications. Group 2 included 38 patients with only diabetic retinopathy. Group 3 included 40 patients with diabetic retinopathy and nephropathy. Trace elements, including chromium (Cr), copper (Cu), and zinc (Zn), were measured by inductively coupled plasma mass spectrophotometry (ICP-MS).</p><p><strong>Results: </strong>Mg levels analyzed by ICP-MS were lower in patients with T2DM than in healthy subjects. Additionally, Mg level of 2.1 mg/dL or less was found to be predictive for risk of occurrence of T2DM with no microvascular complications. Cr levels were significantly lower in T2DM patients with diabetic retinopathy and diabetic nephropathy than in T2DM patients with no microvascular complications. Additionally, levels of Cr were much lower significantly in group 3 than in group 2. The predictive value of Cr levels (area under the curve [AUC]=0.734, P=0.007) for occurrence of diabetic retinopathy was 15.2 μg/L (sensitivity = 70%; specificity = 60.5%).</p><p><strong>Conclusions: </strong>This study showed an association between especially low Mg and Cr levels measured via ICP-MS and microvascular complications in patients with T2DM.</p>","PeriodicalId":18690,"journal":{"name":"Minerva endocrinology","volume":"48 3","pages":"305-310"},"PeriodicalIF":4.1,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10293346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Minerva endocrinologyPub Date : 2023-09-01Epub Date: 2023-02-09DOI: 10.23736/S2724-6507.22.03791-5
Onur Elbasan, Dilek Gogas Yavuz
{"title":"Comparison of staging and recurrence predictors in patients with differentiated thyroid cancer between the 7th and 8th editions of the American Joint Committee on Cancer staging systems.","authors":"Onur Elbasan, Dilek Gogas Yavuz","doi":"10.23736/S2724-6507.22.03791-5","DOIUrl":"10.23736/S2724-6507.22.03791-5","url":null,"abstract":"<p><strong>Background: </strong>The predictive value of American Joint Committee on Cancer (AJCC) 8 for recurrence in differentiated thyroid cancer (DTC) is not known. We aimed to compare AJCC 7 and 8 regarding the differences in staging and recurrence predictors in DTC.</p><p><strong>Methods: </strong>Demographic, clinical (duration of disease and follow-up, the extent of surgery), laboratory (TSH, fT4, thyroglobulin, and antithyroglobulin), pathological (type of thyroid cancer, localization, multifocality, diameter, extrathyroidal extension [ETE], and lymph node [LN] metastasis), and imaging findings (sonography, and whole-body scan), and follow-up features (metastases, recurrence and/or persistence, and RAI need) were retrospectively analyzed in adult patients with DTC followed-up for at least six months. Staging was determined in accordance with AJCC 7 and AJCC 8, prediction of recurrence and persistence by ATA risk stratification, and death risk by AMES systems. The alterations in staging and recurrence predictors were analyzed.</p><p><strong>Results: </strong>A majority of study patients (N.=524) were female (N.=424) and diagnosed with papillary cancer (N.=511), the median age at diagnosis was 44. 97.89% (N.=93) of stage 2-4 patients (N.=95) in AJCC 7 were down-staged in AJCC 8. We down-staged 41 patients of 45-55 years of age into stage 1 in AJCC 8 independent of LN status. A percentage of 26.71% of patients (N.=140) did have persistence, 9.54% (N.=50) persistence at the last follow-up, and 9.54% (N.=50) had recurrence. According to AJCC 8, T4 and AMES high risk were predictors for recurrence (hazard ratio: 3.053, P=0.023; hazard ratio:2.465, and P=0.005; respectively). Both AJCC 7 and 8 were associated with recurrence (P=0.008 and P<0.001, respectively). Stage 4 in AJCC 7, and stages 3 and 4 in AJCC 8 better predicted the probability of recurrence.</p><p><strong>Conclusions: </strong>Our findings suggest that AJCC 8 better predicted the recurrence in DTC than AJCC 7. In AJCC 8, T4 tumor, AMES high risk, stages 3 and 4 predicted recurrence. The vast majority of patients with stages 2-4 in AJCC 7 were down-staged in AJCC 8.</p>","PeriodicalId":18690,"journal":{"name":"Minerva endocrinology","volume":"48 3","pages":"261-273"},"PeriodicalIF":4.1,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10297587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Minerva endocrinologyPub Date : 2023-09-01Epub Date: 2022-10-26DOI: 10.23736/S2724-6507.22.03922-7
Gianluigi Gaspa, Anda M Naciu, Claudia DI Rosa, Greta Lattanzi, Ivan Beato, Vanessa Micheli, Clara Turriziani, Yeganeh M Khazrai, Roberto Cesareo
{"title":"Short- and long-term effects of very low- and low-calorie ketogenic diets on metabolism and cardiometabolic risk factors: a narrative review.","authors":"Gianluigi Gaspa, Anda M Naciu, Claudia DI Rosa, Greta Lattanzi, Ivan Beato, Vanessa Micheli, Clara Turriziani, Yeganeh M Khazrai, Roberto Cesareo","doi":"10.23736/S2724-6507.22.03922-7","DOIUrl":"10.23736/S2724-6507.22.03922-7","url":null,"abstract":"<p><p>Worldwide obesity and cardiovascular diseases have encouraged the adoption of new and efficient dietary strategies. Among various proposed diets, ketogenic diets, both the very-low-calorie ketogenic diet (VLCKD) and the low-calorie ketogenic diet (LCKD), have been suggested in recent years as an effective nutritional approach for obesity management. The VLCKD and the LCKD are characterized by a low carbohydrate content (<50 g/day), 1-1.5 g of protein/kg of ideal body weight, less than 20-30 g of lipids, and a daily intake of about 800 calories for VLCKD and about 1200-1400 calories for LCKD. The purpose of our narrative review is to offer an overview of the most impactful studies in the scientific literature regarding VLCKD and LCKD to discuss their short- and long-term effects (less than 12 months and more than 12 months respectively) on weight loss, metabolic and cardiovascular aspects. Articles we focused on were cohort studies, case-control studies, cross-sectional studies, randomized controlled trials, and meta-analyses. Results indicate that VLCKD and LCKD could be helpful to ameliorate metabolic and cardiovascular risk factors such as weight loss, glucose, and cholesterol levels, both in the short and long term. Further research in this area may include more randomized controlled trials to gather more data.</p>","PeriodicalId":18690,"journal":{"name":"Minerva endocrinology","volume":"48 3","pages":"318-333"},"PeriodicalIF":4.1,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10297072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ricardo E Ramírez-Orozco, Juan M Malacara, Nicté Figueroa-Vega
{"title":"Obesity as a negative mediator of serine-118/serine-105 phosphorylation sites on ERα/ERβ through the ovarian cycle.","authors":"Ricardo E Ramírez-Orozco, Juan M Malacara, Nicté Figueroa-Vega","doi":"10.23736/S2724-6507.22.03848-9","DOIUrl":"https://doi.org/10.23736/S2724-6507.22.03848-9","url":null,"abstract":"","PeriodicalId":18690,"journal":{"name":"Minerva endocrinology","volume":"48 3","pages":"361-364"},"PeriodicalIF":4.1,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41107312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Minerva endocrinologyPub Date : 2023-09-01Epub Date: 2023-06-16DOI: 10.23736/S2724-6507.23.04017-4
Antongiulio Faggiano, Elisa Giannetta, Roberta Modica, Manuela Albertelli, Livia Barba, Pasquale Dolce, Cecilia Motta, Maria G Deiana, Ruggero Martinelli, Virginia Zamponi, Franz Sesti, Luca Patti, Francesco Scavuzzo, Annamaria Colao, Salvatore Monti
{"title":"Calcium-stimulated calcitonin test for the diagnosis of medullary thyroid cancer: results of a multicenter study and comparison between different assays.","authors":"Antongiulio Faggiano, Elisa Giannetta, Roberta Modica, Manuela Albertelli, Livia Barba, Pasquale Dolce, Cecilia Motta, Maria G Deiana, Ruggero Martinelli, Virginia Zamponi, Franz Sesti, Luca Patti, Francesco Scavuzzo, Annamaria Colao, Salvatore Monti","doi":"10.23736/S2724-6507.23.04017-4","DOIUrl":"10.23736/S2724-6507.23.04017-4","url":null,"abstract":"<p><strong>Background: </strong>A basal serum calcitonin (Ct) increase >100 pg/mL in patients with a thyroid nodule is consistent with the diagnosis of medullary thyroid cancer (MTC). In cases where the CT test have a slight to moderate increase, the calcium gluconate stimulation test is helpful to increase diagnostic accuracy. However, reliable cut-offs for calcium-stimulated Ct are still lacking. The aim of this study was to evaluate the sex-specific calcium-stimulated Ct cutoffs for the diagnosis of MTC in a multicenter series. A comparison between different Ct assays has been also performed.</p><p><strong>Methods: </strong>90 subjects undergone calcium-stimulated Ct for a suspected MTC in 5 Endocrine Units between 2010-2021 were retrospectively analyzed. Serum Ct concentrations were assessed by immunoradiometric (IRMA) or chemiluminescence (CLIA) assays.</p><p><strong>Results: </strong>MTC was diagnosed in 37 (41.1%) and excluded in 53 (58.9%) patients. The best calcium-stimulated Ct cut-off to identify MTC was 611 pg/mL in males (AUC =0.90, 95% CI (0.76;1) and 445 pg/mL in females (AUC=0.79, 95% CI (0.66;0.91). Logistic regression analysis showed that both basal (OR 1.01, P=0.003) and peak Ct after stimulation (OR 1.07, P=0.007) were significantly associated with MTC, together with sex (OR=0.06, P<0.001). The \"Ct assay\" variable was also considered in the logistic regression model, but it was not significantly associated with MTC (OR=0.93, P=0.919).</p><p><strong>Conclusions: </strong>This study indicates that calcium test could be helpful to identify patients with early-stage MTC and those without MTC. A Ct value of 611 pg/mL in males and 445 pg/mL in females are proposed as the optimal Ct cut-offs at the stimulation test.</p>","PeriodicalId":18690,"journal":{"name":"Minerva endocrinology","volume":"48 3","pages":"253-260"},"PeriodicalIF":4.1,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10302156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Minerva endocrinologyPub Date : 2023-09-01Epub Date: 2021-05-12DOI: 10.23736/S2724-6507.21.03465-5
Eren Imre, Hatice G Gunhan, Pinar Erel, Ozlem Ustay
{"title":"SGLT2 inhibitors improve plasma atherogenic biomarkers in patients with type 2 diabetes: a real-world retrospective observational study.","authors":"Eren Imre, Hatice G Gunhan, Pinar Erel, Ozlem Ustay","doi":"10.23736/S2724-6507.21.03465-5","DOIUrl":"10.23736/S2724-6507.21.03465-5","url":null,"abstract":"<p><strong>Background: </strong>There are cost-effective, non-invasive, and predictive tools used to predict the CVD risk in patients with diabetes such as the \"atherogenic index of plasma (AIP)\" which is defined as the logarithm to the base 10 of the ratio of fasting plasma TG (mg/dL) to HDL-C [log (TG/HDL-C)], triglyceride to high density lipoprotein (TG-to-HDL-C) ratio and the triglyceride glucose (TyG) index which is calculated as Ln (fasting TG [mg/dL] × fasting blood glucose (mg/dL)/2). These tools are indirect markers of atherosclerosis. Dapagliflozin and empagliflozin have exhibited cardiovascular beneficial effects and this study evaluated the effects of sodium glucose cotransporter 2 inhibitors (SGLT2i) on AIP, TyG index and TG-to-HDL-C ratio in patients with type 2 diabetes.</p><p><strong>Methods: </strong>This single center, retrospective, observational study involved patients with type 2 diabetic patients who were prescribed SGLT2i in the endocrinology outpatient clinic between January 2017 and June 2019. Demographic and clinical data were collected from patient files. AIP, TyG index and TG-to-HDL-C ratio were calculated obtained at the first visit and the sixth month visit.</p><p><strong>Results: </strong>Overall, 143 patients with T2DM (75 women, 68 men) were recruited in this study. Sixty-six patients were prescribed dapagliflozin (46.2%), and 77 were prescribed empagliflozin (53.8%). SGLT2i treatment did not alter the lipid profile except the serum triglyceride (TG) levels. Serum TG levels were significantly reduced after 6 months of SGLT2i therapy (P=0.045). All patients had significant reductions in AIP at 6-month follow-up (P<0.001), accompanied by a significant reduction in TyG index (P<0.001). Both empagliflozin and dapagliflozin caused significant decrease in AIP (P=0.043 and P<0.001, respectively) and TyG index (P=0.010 and P<0.001, respectively).</p><p><strong>Conclusions: </strong>Both dapagliflozin and empagliflozin were noted to significantly affect AIP and TyG indexes, which indicate atherosclerotic cardiovascular risk, with or without statin treatment regardless of lipid parameters.</p>","PeriodicalId":18690,"journal":{"name":"Minerva endocrinology","volume":"48 3","pages":"295-304"},"PeriodicalIF":4.1,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10294164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}